Multilingual Fentanyl Awareness Resources Released
September 19, 2024 07:00 ET
|
Addiction Policy Forum
Addiction Policy Forum has launched fentanyl education resources in 12 languages to help more communities understand the dangers of counterfeit pills.
ARCPOINT ADDS FUNCTIONALITY TO ENABLE TELEHEALTH PRACTITIONERS TO ORDER DIAGNOTIC TESTS THROUGH ARCPOINT SYSTEM
September 18, 2024 16:35 ET
|
ARCpoint Inc.
Greenville, South Carolina, Sept. 18, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to report that it has implemented an integration that allows...
Leading Dermatologic Associations and Skin Cancer Prevention Organizations Urge U.S. Surgeon General to Renew Skin Cancer Call to Action
September 18, 2024 12:46 ET
|
American Society for Dermatologic Surgery Association
Schaumburg, Ill., Sept. 18, 2024 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery Association (ASDSA), in conjunction with the American Academy of Dermatology Association (AAD), the...
Atenolol Market Report 2024: Growing Demand for Beta-1 Selective Blockers, Regulatory Approvals for New Formulations and Rising Demand for Combination Therapies in Treating Cardiovascular Conditions
September 17, 2024 08:59 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Atenolol Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The atenolol market size has grown strongly in recent years,...
Noom Appoints Rachel Mahoney as Chief Brand Officer
September 17, 2024 08:02 ET
|
Noom Inc
Noom is pleased to announce the appointment of Rachel Mahoney as Chief Brand Officer.
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients
September 16, 2024 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
Cullinan Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for CLN-978 to Treat Systemic Lupus Erythematosus
September 16, 2024 07:00 ET
|
Cullinan Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today shared...
Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency
September 16, 2024 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
The World Health Organization (WHO) released its preferred target product profile (TPP) criteria for mpox vaccines at its Mpox Research and Innovation Scientific Conference held August 29-30 TNX-801,...
Nicotine Replacement Therapy Market Size to Hit USD 4.27 Billion by 2032- Exclusive Report by SNS Insider
September 13, 2024 10:07 ET
|
SNS Insider pvt ltd
Pune, Sept. 13, 2024 (GLOBE NEWSWIRE) -- According to New Research Report “Nicotine Replacement Therapy Market Size, Share Analysis By Type (Gums, Patches, Lozenges, Inhalers, and Others), By...
Africa Syringes Market, Revenue, Analysis, Industry, Growth, Trends, Companies & Forecast 2024-2030
September 12, 2024 11:35 ET
|
Research and Markets
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "Africa Syringes Market (2024-2030): Value, Revenue, Analysis, Industry, Growth, Trends, Companies, Forecast, Size, Outlook & Share: Market...